Loading clinical trials...
Loading clinical trials...
Immunomodulatory Effects of Vitamin D in Chronic Hemodialysis Patients
The purpose of this study to examine whether vitamin D can reduce the activation of the immune system during dialysis. When activated, the immune cells release certain substances, called cytokines, which can be measured from small blood samples. We want to study to what degree the immune system is activated during a regular dialysis treatment and whether the time point of vitamin D administration, either right before the start or right at the end of a dialysis treatment, has an impact on the activation of the immune system.
Age
18 - 75 years
Sex
ALL
Healthy Volunteers
No
Irving Place Dialysis Center
New York, New York, United States
Upper Manhattan Dialysis Center
New York, New York, United States
Yorkville Dialysis Center
New York, New York, United States
Start Date
December 1, 2004
Primary Completion Date
September 1, 2007
Completion Date
September 1, 2007
Last Updated
May 13, 2009
20
ACTUAL participants
paricalcitol
DRUG
Lead Sponsor
Renal Research Institute
Collaborators
NCT07462741
NCT07146854
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04163614